Global Influenza Drugs Market 2017 - Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022

 Buy Now

   Published Date : Sep-2017   |    Format : PDF   |    Pages : 115
In this report, the global Influenza Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Influenza Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Influenza Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Bristol-Myers Squibb]
    AstraZeneca
    Eli Lilly
    Roche
    GlaxoSmithKline
    Novartis
    Pfizer
    Sanofi Pasteur
    Bayer
    Celgene
    Seqirus
    Protein Sciences Corporation
    Serum Institute of India
    Emergent Biosolutions
    BioCryst Pharmaceuticals
    Alvogen
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Zanamivir
    Oseltamivir Phosphate
    Peramivir
    Other Influenza Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Influenza Drugs for each application, including
    Adults
    Chidren

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Influenza Drugs Market Research Report 2017
1 Influenza Drugs Market Overview
    1.1 Product Overview and Scope of Influenza Drugs
    1.2 Influenza Drugs Segment by Type (Product Category)
        1.2.1 Global Influenza Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Influenza Drugs Production Market Share by Type (Product Category) in 2016
        1.2.3 Zanamivir
        1.2.4 Oseltamivir Phosphate
        1.2.5 Peramivir
        1.2.6 Other Influenza Drugs
    1.3 Global Influenza Drugs Segment by Application
        1.3.1 Influenza Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Adults
        1.3.3 Chidren
    1.4 Global Influenza Drugs Market by Region (2012-2022)
        1.4.1 Global Influenza Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Influenza Drugs (2012-2022)
        1.5.1 Global Influenza Drugs Revenue Status and Outlook (2012-2022)
        1.5.2 Global Influenza Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Influenza Drugs Market Competition by Manufacturers
    2.1 Global Influenza Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Influenza Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Influenza Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global Influenza Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Influenza Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Influenza Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Influenza Drugs Market Competitive Situation and Trends
        2.5.1 Influenza Drugs Market Concentration Rate
        2.5.2 Influenza Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Influenza Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Influenza Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global Influenza Drugs Production and Market Share by Region (2012-2017)
    3.3 Global Influenza Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Influenza Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Influenza Drugs Consumption by Region (2012-2017)
    4.2 North America Influenza Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Influenza Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Influenza Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Influenza Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Influenza Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Influenza Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Influenza Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Influenza Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Influenza Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Influenza Drugs Price by Type (2012-2017)
    5.4 Global Influenza Drugs Production Growth by Type (2012-2017)

6 Global Influenza Drugs Market Analysis by Application
    6.1 Global Influenza Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Influenza Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Influenza Drugs Manufacturers Profiles/Analysis
    7.1 Bristol-Myers Squibb]
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Influenza Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Bristol-Myers Squibb] Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 AstraZeneca
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Influenza Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 AstraZeneca Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Eli Lilly
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Influenza Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Eli Lilly Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Roche
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Influenza Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Roche Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 GlaxoSmithKline
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Influenza Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 GlaxoSmithKline Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Novartis
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Influenza Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Novartis Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Pfizer
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Influenza Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Pfizer Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Sanofi Pasteur
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Influenza Drugs Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Sanofi Pasteur Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Bayer
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Influenza Drugs Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Bayer Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Celgene
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Influenza Drugs Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Celgene Influenza Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Seqirus
    7.12 Protein Sciences Corporation
    7.13 Serum Institute of India
    7.14 Emergent Biosolutions
    7.15 BioCryst Pharmaceuticals
    7.16 Alvogen

8 Influenza Drugs Manufacturing Cost Analysis
    8.1 Influenza Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Influenza Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Influenza Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Influenza Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Influenza Drugs Market Forecast (2017-2022)
    12.1 Global Influenza Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Influenza Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Influenza Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Influenza Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Influenza Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Influenza Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Influenza Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Influenza Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Influenza Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Influenza Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Influenza Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Influenza Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Influenza Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer


List of Tables and Figures

    Figure Picture of Influenza Drugs
    Figure Global Influenza Drugs Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
    Figure Global Influenza Drugs Production Market Share by Types (Product Category) in 2016
    Figure Product Picture of Zanamivir
    Table Major Manufacturers of Zanamivir
    Figure Product Picture of Oseltamivir Phosphate
    Table Major Manufacturers of Oseltamivir Phosphate
    Figure Product Picture of Peramivir
    Table Major Manufacturers of Peramivir
    Figure Product Picture of Other Influenza Drugs
    Table Major Manufacturers of Other Influenza Drugs
    Figure Global Influenza Drugs Consumption (K MT) by Applications (2012-2022)
    Figure Global Influenza Drugs Consumption Market Share by Applications in 2016
    Figure Adults Examples
    Table Key Downstream Customer in Adults
    Figure Chidren Examples
    Table Key Downstream Customer in Chidren
    Figure Global Influenza Drugs Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions (2012-2022)
    Figure North America Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure China Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Japan Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southeast Asia Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure India Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Global Influenza Drugs Revenue (Million USD) Status and Outlook (2012-2022)
    Figure Global Influenza Drugs Capacity, Production (K MT) Status and Outlook (2012-2022)
    Figure Global Influenza Drugs Major Players Product Capacity (K MT) (2012-2017)
    Table Global Influenza Drugs Capacity (K MT) of Key Manufacturers (2012-2017)
    Table Global Influenza Drugs Capacity Market Share of Key Manufacturers (2012-2017)
    Figure Global Influenza Drugs Capacity (K MT) of Key Manufacturers in 2016
    Figure Global Influenza Drugs Capacity (K MT) of Key Manufacturers in 2017
    Figure Global Influenza Drugs Major Players Product Production (K MT) (2012-2017)
    Table Global Influenza Drugs Production (K MT) of Key Manufacturers (2012-2017)
    Table Global Influenza Drugs Production Share by Manufacturers (2012-2017)
    Figure 2016 Influenza Drugs Production Share by Manufacturers
    Figure 2017 Influenza Drugs Production Share by Manufacturers
    Figure Global Influenza Drugs Major Players Product Revenue (Million USD) (2012-2017)
    Table Global Influenza Drugs Revenue (Million USD) by Manufacturers (2012-2017)
    Table Global Influenza Drugs Revenue Share by Manufacturers (2012-2017)
    Table 2016 Global Influenza Drugs Revenue Share by Manufacturers
    Table 2017 Global Influenza Drugs Revenue Share by Manufacturers
    Table Global Market Influenza Drugs Average Price (USD/MT) of Key Manufacturers (2012-2017)
    Figure Global Market Influenza Drugs Average Price (USD/MT) of Key Manufacturers in 2016
    Table Manufacturers Influenza Drugs Manufacturing Base Distribution and Sales Area
    Table Manufacturers Influenza Drugs Product Category
    Figure Influenza Drugs Market Share of Top 3 Manufacturers
    Figure Influenza Drugs Market Share of Top 5 Manufacturers
    Table Global Influenza Drugs Capacity (K MT) by Region (2012-2017)
    Figure Global Influenza Drugs Capacity Market Share by Region (2012-2017)
    Figure Global Influenza Drugs Capacity Market Share by Region (2012-2017)
    Figure 2016 Global Influenza Drugs Capacity Market Share by Region
    Table Global Influenza Drugs Production by Region (2012-2017)
    Figure Global Influenza Drugs Production (K MT) by Region (2012-2017)
    Figure Global Influenza Drugs Production Market Share by Region (2012-2017)
    Figure 2016 Global Influenza Drugs Production Market Share by Region
    Table Global Influenza Drugs Revenue (Million USD) by Region (2012-2017)
    Table Global Influenza Drugs Revenue Market Share by Region (2012-2017)
    Figure Global Influenza Drugs Revenue Market Share by Region (2012-2017)
    Table 2016 Global Influenza Drugs Revenue Market Share by Region
    Figure Global Influenza Drugs Capacity, Production (K MT) and Growth Rate (2012-2017)
    Table Global Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Table North America Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Table Europe Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Table China Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Table Japan Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Table Southeast Asia Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Table India Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Table Global Influenza Drugs Consumption (K MT) Market by Region (2012-2017)
    Table Global Influenza Drugs Consumption Market Share by Region (2012-2017)
    Figure Global Influenza Drugs Consumption Market Share by Region (2012-2017)
    Figure 2016 Global Influenza Drugs Consumption (K MT) Market Share by Region
    Table North America Influenza Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
    Table Europe Influenza Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
    Table China Influenza Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
    Table Japan Influenza Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
    Table Southeast Asia Influenza Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
    Table India Influenza Drugs Production, Consumption, Import & Export (K MT) (2012-2017)
    Table Global Influenza Drugs Production (K MT) by Type (2012-2017)
    Table Global Influenza Drugs Production Share by Type (2012-2017)
    Figure Production Market Share of Influenza Drugs by Type (2012-2017)
    Figure 2016 Production Market Share of Influenza Drugs by Type
    Table Global Influenza Drugs Revenue (Million USD) by Type (2012-2017)
    Table Global Influenza Drugs Revenue Share by Type (2012-2017)
    Figure Production Revenue Share of Influenza Drugs by Type (2012-2017)
    Figure 2016 Revenue Market Share of Influenza Drugs by Type
    Table Global Influenza Drugs Price (USD/MT) by Type (2012-2017)
    Figure Global Influenza Drugs Production Growth by Type (2012-2017)
    Table Global Influenza Drugs Consumption (K MT) by Application (2012-2017)
    Table Global Influenza Drugs Consumption Market Share by Application (2012-2017)
    Figure Global Influenza Drugs Consumption Market Share by Applications (2012-2017)
    Figure Global Influenza Drugs Consumption Market Share by Application in 2016
    Table Global Influenza Drugs Consumption Growth Rate by Application (2012-2017)
    Figure Global Influenza Drugs Consumption Growth Rate by Application (2012-2017)
    Table Bristol-Myers Squibb] Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Bristol-Myers Squibb] Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Bristol-Myers Squibb] Influenza Drugs Production Growth Rate (2012-2017)
    Figure Bristol-Myers Squibb] Influenza Drugs Production Market Share (2012-2017)
    Figure Bristol-Myers Squibb] Influenza Drugs Revenue Market Share (2012-2017)
    Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table AstraZeneca Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure AstraZeneca Influenza Drugs Production Growth Rate (2012-2017)
    Figure AstraZeneca Influenza Drugs Production Market Share (2012-2017)
    Figure AstraZeneca Influenza Drugs Revenue Market Share (2012-2017)
    Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Eli Lilly Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Eli Lilly Influenza Drugs Production Growth Rate (2012-2017)
    Figure Eli Lilly Influenza Drugs Production Market Share (2012-2017)
    Figure Eli Lilly Influenza Drugs Revenue Market Share (2012-2017)
    Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Roche Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Roche Influenza Drugs Production Growth Rate (2012-2017)
    Figure Roche Influenza Drugs Production Market Share (2012-2017)
    Figure Roche Influenza Drugs Revenue Market Share (2012-2017)
    Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table GlaxoSmithKline Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure GlaxoSmithKline Influenza Drugs Production Growth Rate (2012-2017)
    Figure GlaxoSmithKline Influenza Drugs Production Market Share (2012-2017)
    Figure GlaxoSmithKline Influenza Drugs Revenue Market Share (2012-2017)
    Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Novartis Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Novartis Influenza Drugs Production Growth Rate (2012-2017)
    Figure Novartis Influenza Drugs Production Market Share (2012-2017)
    Figure Novartis Influenza Drugs Revenue Market Share (2012-2017)
    Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Pfizer Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Pfizer Influenza Drugs Production Growth Rate (2012-2017)
    Figure Pfizer Influenza Drugs Production Market Share (2012-2017)
    Figure Pfizer Influenza Drugs Revenue Market Share (2012-2017)
    Table Sanofi Pasteur Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Sanofi Pasteur Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Sanofi Pasteur Influenza Drugs Production Growth Rate (2012-2017)
    Figure Sanofi Pasteur Influenza Drugs Production Market Share (2012-2017)
    Figure Sanofi Pasteur Influenza Drugs Revenue Market Share (2012-2017)
    Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Bayer Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Bayer Influenza Drugs Production Growth Rate (2012-2017)
    Figure Bayer Influenza Drugs Production Market Share (2012-2017)
    Figure Bayer Influenza Drugs Revenue Market Share (2012-2017)
    Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Celgene Influenza Drugs Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
    Figure Celgene Influenza Drugs Production Growth Rate (2012-2017)
    Figure Celgene Influenza Drugs Production Market Share (2012-2017)
    Figure Celgene Influenza Drugs Revenue Market Share (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Influenza Drugs
    Figure Manufacturing Process Analysis of Influenza Drugs
    Figure Influenza Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Influenza Drugs Major Manufacturers in 2016
    Table Major Buyers of Influenza Drugs
    Table Distributors/Traders List
    Figure Global Influenza Drugs Capacity, Production (K MT) and Growth Rate Forecast (2017-2022)
    Figure Global Influenza Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Influenza Drugs Price (Million USD) and Trend Forecast (2017-2022)
    Table Global Influenza Drugs Production (K MT) Forecast by Region (2017-2022)
    Figure Global Influenza Drugs Production Market Share Forecast by Region (2017-2022)
    Table Global Influenza Drugs Consumption (K MT) Forecast by Region (2017-2022)
    Figure Global Influenza Drugs Consumption Market Share Forecast by Region (2017-2022)
    Figure North America Influenza Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
    Figure North America Influenza Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table North America Influenza Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
    Figure Europe Influenza Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
    Figure Europe Influenza Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Europe Influenza Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
    Figure China Influenza Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
    Figure China Influenza Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table China Influenza Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
    Figure Japan Influenza Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
    Figure Japan Influenza Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Japan Influenza Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
    Figure Southeast Asia Influenza Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Influenza Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Southeast Asia Influenza Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
    Figure India Influenza Drugs Production (K MT) and Growth Rate Forecast (2017-2022)
    Figure India Influenza Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table India Influenza Drugs Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
    Table Global Influenza Drugs Production (K MT) Forecast by Type (2017-2022)
    Figure Global Influenza Drugs Production (K MT) Forecast by Type (2017-2022)
    Table Global Influenza Drugs Revenue (Million USD) Forecast by Type (2017-2022)
    Figure Global Influenza Drugs Revenue Market Share Forecast by Type (2017-2022)
    Table Global Influenza Drugs Price Forecast by Type (2017-2022)
    Table Global Influenza Drugs Consumption (K MT) Forecast by Application (2017-2022)
    Figure Global Influenza Drugs Consumption (K MT) Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Source



Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...